These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9025227)

  • 1. Resistance to HIV infection: the genes are only part of the solution.
    Clerici M; Clivio A; Shearer GM
    Trends Microbiol; 1997 Jan; 5(1):2-4. PubMed ID: 9025227
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 3. Host factors and the pathogenesis of HIV-induced disease.
    Fauci AS
    Nature; 1996 Dec; 384(6609):529-34. PubMed ID: 8955267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tracking down natural resistance to HIV. Defective cellular receptor prevents entrance of virus into the cell].
    Hobom B
    Fortschr Med; 1996 Oct; 114(29):12, 14. PubMed ID: 9005198
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
    Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to HIV infection.
    Paxton WA; Koup RA
    Springer Semin Immunopathol; 1997; 18(3):323-40. PubMed ID: 9089952
    [No Abstract]   [Full Text] [Related]  

  • 7. Host genes and HIV infection: implications and applications.
    Kaslow RA
    Emerg Infect Dis; 1997; 3(3):401-2. PubMed ID: 9284391
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to HIV-1 infection: it's in the genes.
    Fauci AS
    Nat Med; 1996 Sep; 2(9):966-7. PubMed ID: 8782446
    [No Abstract]   [Full Text] [Related]  

  • 9. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
    Dolan MJ; Kulkarni H; Camargo JF; He W; Smith A; Anaya JM; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RA; Anderson SA; Delmar J; O'Connell RJ; Lloyd A; Martin J; Ahuja SS; Agan BK; Walker BD; Deeks SG; Ahuja SK
    Nat Immunol; 2007 Dec; 8(12):1324-36. PubMed ID: 17952079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    McNicholl JM; Smith DK; Qari SH; Hodge T
    Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD; Whittaker KM; Choi R; Tashkin DP; Baldwin GC
    J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host resistance to malaria runs into swampy water.
    Wilkinson RJ; Pasvol G
    Trends Microbiol; 1997 Jun; 5(6):213-5. PubMed ID: 9211638
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-macrophage interactions at the cellular and molecular level.
    Khati M; James W; Gordon S
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):367-78. PubMed ID: 11798135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning of new receptors used by simian and human immunodeficiency viruses.
    Deng HK; Unutmaz D; KewalRamani VN; Littman DR
    Nature; 1997 Jul; 388(6639):296-300. PubMed ID: 9230441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
    J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
    de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
    J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.